Skip to main content

Women’s Health Diagnostics Market | High Prevalence of Infectious Diseases in Women

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.


Target Audience:

  • Hospitals and Clinics
  • Medical Research and Development (R&D) Companies
  • Medical Device Companies
  • Women Health Diagnostics Solutions’ Vendors
  • Medical Device Manufacturers
  • Imaging and Diagnostic Centers
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
To know about the assumptions considered for the study, download the pdf brochure

Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) – Forecast to 2021

Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Scope of the Report:

The research report categorizes the women’s health diagnostics market into the following segments and subsegments:

Global women’s health diagnostics market, by application

  • Breast Cancer Testing
    • Mammography Systems
    • Breast Cancer Tumor Marker Tests
    • Blood Chemistries and Blood Cell Count
    • Biopsies
    • Other Diagnostic Imaging Tests
  • Infectious Disease Testing
    • Urinary Tract Infection Testing
    • MRSA Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Testing
  • Cervical Cancer Testing
    • Pap Smear
    • HPV Testing
  • Osteoporosis Testing
    • Bone Densitometry
    • In Vitro Blood Tests
  • Sexually Transmitted Disease Testing
    • Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
    • HIV Testing
    • Other Sexually Transmitted Diseases
  • Prenatal Genetic Screening and Carrier Testing
    • Cystic Fibrosis
    • Down Syndrome and Edward Syndrome
    • TORCH Infections
    • Other Diseases
  • Ultrasound
    • OB/GYN Imaging
    • Breast Imaging
  • Pregnancy and Fertility Testing
    • Pregnancy Testing and Ovulation Prediction Kits
    • Lab-based Testing
    • Fertility Monitors
  • Ovarian Cancer Testing
    • Ovarian Cancer Tumor Marker Tests
    • Diagnostic Imaging Tests
    • Other Tests

What are the Women’s Health Diagnostics Market Segments?

The global market has been segmented, on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound.

Leading market players and strategies adopted

The prominent players in this market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

For more details, visit: https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html

Comments

Popular posts from this blog

Inspection Machines Market To Reach USD 871 Million By 2025 - Growing Demand For Personalized Medicine

  What This Report Will Provide? This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. Expected Revenue Growth: The  Inspection machines market  is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period. Major Growth Boosters: The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices ( GMP ). Download PDF Brochure:    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085   CO...

Health Information Exchange (HIE) Market Worth USD 2.0 Billion By 2025 : Growing Adoption Of EHRs

  What This Report Will Provide?  This study involved four major activities in estimating the size of the health information exchange market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. Expected Revenue Growth: [199 Pages Report]  The  global health information exchange market  is expected to reach USD 2.0 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 12.2%. Major Growth Boosters: Growth in this market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperabilit...

What are the growth opportunities offered by the Digital Therapeutic (DTx) Market in the next five years?

  The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance. The global  digital therapeutics market  is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025). On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent. Market Dynamics 1. Increasing incidence of preventable chronic diseases 2. Risi...